Objective: This study sought to examine the prospective effects of early adolescent marijuana use on late adolescent attentional and inhibitory control. Alcohol use, antisocial problems, and gender were included as statistical control variables.
Method: The community sample of 387 adolescents and a caregiver was drawn from a longitudinal study of adolescent substance use that included nine annual assessments. Adolescents were eligible if they were between ages 11 and 12 at recruitment and did not have any disabilities that would preclude them from either understanding or completing the assessment. The sample was evenly split on gender (55% female) and was predominantly non-Hispanic White (83.16%) or African American (9.07%). Attentional and inhibitory control were assessed using parent and adolescent self-reports on the Early Adolescent Temperament Questionnaire-Revised and the Adult Temperament Questionnaire.
Results: Hypotheses were tested using structural equation modeling. High levels of early marijuana use at ages 12-14 significantly predicted low levels of adolescent attentional control at ages 18-21 (β = -.20, p < .05), above and beyond early attentional control, early alcohol use, and antisocial problems.
Conclusions: Findings suggest that marijuana use may adversely affect cognitive development, especially during the sensitive period of early adolescence. Results emphasize the need for further prospective work to investigate relationships between early adolescent marijuana use and the development of executive functioning.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201210 | PMC |
http://dx.doi.org/10.15288/jsad.2020.81.164 | DOI Listing |
Soa Chongsonyon Chongsin Uihak
January 2025
Department of Psychiatry, Seoul National University Hospital, Seoul, Korea.
Objectives: This study examined the neurocognitive profiles of early adulthood attention-deficit/hyperactivity disorder (ADHD) patients using the Korean version of the Wechsler Adult Intelligence Scale, 4th Edition (K-WAIS-IV) and Continuous Performance Test 3rd Edition (CPT-3) assessment results.
Methods: A total of 105 individuals underwent the K-WAIS-IV assessment, and 68 participants completed the CPT-3. We examined the differences between intelligence subindex scores using paired t-tests and applied Pearson's correlation analysis to determine the correlation between the K-WAIS-IV and CPT-3 scores.
Neurobiol Stress
January 2025
Stanford University, Department of Psychology, 450 Jane Stanford Way, Stanford, CA, 94305, USA.
Researchers have documented that exposure to different kinds of psychosocial stressors can lead to emotional difficulties and, further, that heightened reactivity to stress can moderate these associations. Recently, investigators have distinguished among threat, deprivation, and unpredictability as different dimensions of early life stress (ELS). It is not clear, however, whether reactivity in specific stress response systems functions as a diathesis to lead to emotional difficulties following exposure to these dimensions of ELS.
View Article and Find Full Text PDFKidney Int Rep
January 2025
Division of Pediatric Nephrology, Rosenheim Hospital, Germany.
Introduction: Newborn screening (NBS) programs for a defined set of eligible diseases have been enormously successful, but genomic NBS allowing for detection of additional treatable disorders has not been broadly implemented. All 3 types of primary hyperoxaluria (PH1-3) are rare autosomal recessive diseases caused by distinct defects of glyoxylate metabolism that are diagnosed genetically with certainty. Early diagnosis and treatment are mandatory to avoid renal failure or sequalae associated with persistent hyperoxaluria.
View Article and Find Full Text PDFWorld Psychiatry
February 2025
Child and Adolescent Mental Health Centre, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.
Antipsychotic treatment is associated with cardiometabolic risks that may be especially detrimental to children and adolescents. In this Danish population-based cohort study, we included individuals with psychiatric diagnoses who initiated antipsychotics in 2000-2021 at age 6-31 years. We assessed the risk of cardiometabolic adverse events up to 10 years following incident exposure to antipsychotics, compared to age- and sex-matched unexposed individuals with psychiatric diagnoses.
View Article and Find Full Text PDFCan J Psychiatry
January 2025
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Objectives: To establish whether the risk of psychotic disorders in cannabis users changes with time following cannabis cessation using data from the European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI) case-control study.
Methods: The EU-GEI case-control study collected data from first episode psychosis patients and population controls across sites in Europe and Brazil between May 2010 and April 2015. Adjusted logistic regressions were applied to examine whether the odd of psychosis case status changed: (1) with time following cannabis cessation and (2) across different cannabis use groups.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!